• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西坎皮纳斯市癌症筛查检测使用情况的患病率及社会不平等现象(ISACamp 2014/15)

Prevalence and social inequalities in the use of cancer screening tests in Campinas, Brazil (ISACamp 2014/15).

作者信息

Lima Bianca Gastaldon, Barros Marilisa Berti de Azevedo

机构信息

Universidade Estadual de Campinas, Faculty of Medical Sciences, Department of Collective Health - Campinas (SP), Brazil.

出版信息

Rev Bras Epidemiol. 2025 Aug 4;28:e250043. doi: 10.1590/1980-549720250043. eCollection 2025.

DOI:10.1590/1980-549720250043
PMID:40767679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12321152/
Abstract

OBJECTIVE

To analyze the prevalence of early detection tests for cervical, breast, prostate, and colorectal cancers in the population of Campinas, São Paulo and the presence of social inequalities in access.

METHODS

Population-based cross-sectional study using data from ISACamp 2014/15. Dependent variables were the performance of Pap smear, mammogram, prostate-specific antigen (PSA), fecal occult blood test (FOBT) and colonoscopy/sigmoidoscopy within the age ranges recommended by national guidelines. Independent variables included sex, age, schooling, income, race/skin color, and private health insurance. Prevalence and prevalence ratio adjusted for sex and age were estimated using Poisson regression. Analyses were performed using Stata 14, considering sampling weights.

RESULTS

The prevalence of mammography (77.7%) and Pap smear (87.8%) met the targets set by the Brazilian Ministry of Health, while FOBT (22.3%) and colonoscopy/sigmoidoscopy (21.5%) showed low coverage. PSA testing in the previous three years was reported by 55.2% of eligible men. Higher prevalence of test performance was observed among individuals with higher schooling and income levels and those with private health insurance. Inequalities varied by type of test. For instance, individuals with private health insurance had 11 and 162% higher prevalence of Pap test and colonoscopy/sigmoidoscopy, respectively, compared to those without insurance. Racial inequality was observed only for mammography.

CONCLUSION

The results indicate high coverage and lower inequalities for Pap and mammography, and low coverage with significant disparities for FOBT and colonoscopy/sigmoidoscopy. Findings highlight the need to monitor coverage and to implement public policies aimed at reducing inequities in access to cancer screening.

摘要

目的

分析圣保罗州坎皮纳斯市人群中宫颈癌、乳腺癌、前列腺癌和结直肠癌早期检测测试的普及率以及获取检测服务方面的社会不平等现象。

方法

基于人群的横断面研究,使用2014/15年坎皮纳斯市健康调查(ISACamp)的数据。因变量为在国家指南推荐的年龄范围内进行巴氏涂片检查、乳房X光检查、前列腺特异性抗原(PSA)检测、粪便潜血试验(FOBT)以及结肠镜检查/乙状结肠镜检查的情况。自变量包括性别、年龄、受教育程度、收入、种族/肤色以及私人医疗保险。使用泊松回归估计经性别和年龄调整后的患病率及患病率比。分析使用Stata 14软件进行,并考虑抽样权重。

结果

乳房X光检查(77.7%)和巴氏涂片检查(87.8%)的普及率达到了巴西卫生部设定的目标,而FOBT(22.3%)和结肠镜检查/乙状结肠镜检查(21.5%)的覆盖率较低。在符合条件的男性中,有55.2%报告在过去三年中进行过PSA检测。受教育程度和收入水平较高以及拥有私人医疗保险的人群检测执行率更高。不平等情况因检测类型而异。例如,与没有保险的人相比,拥有私人医疗保险的人进行巴氏试验和结肠镜检查/乙状结肠镜检查的患病率分别高出11%和162%。仅在乳房X光检查中观察到种族不平等。

结论

结果表明,巴氏涂片检查和乳房X光检查的覆盖率较高且不平等程度较低,而FOBT和结肠镜检查/乙状结肠镜检查的覆盖率较低且存在显著差异。研究结果凸显了监测覆盖率以及实施旨在减少癌症筛查获取方面不平等现象的公共政策的必要性。

相似文献

1
Prevalence and social inequalities in the use of cancer screening tests in Campinas, Brazil (ISACamp 2014/15).巴西坎皮纳斯市癌症筛查检测使用情况的患病率及社会不平等现象(ISACamp 2014/15)
Rev Bras Epidemiol. 2025 Aug 4;28:e250043. doi: 10.1590/1980-549720250043. eCollection 2025.
2
Breast cancer screening coverage is severely reduced among women who reside in segregated areas: a cross-sectional investigation in Hungary.居住在隔离区域的女性中乳腺癌筛查覆盖率大幅降低:匈牙利的一项横断面调查。
Front Public Health. 2025 Jul 14;13:1500098. doi: 10.3389/fpubh.2025.1500098. eCollection 2025.
3
Determinants of cancer screening participation in Türkiye: a nationwide study of demographic, socioeconomic, and lifestyle factors.土耳其癌症筛查参与率的决定因素:一项关于人口、社会经济和生活方式因素的全国性研究。
BMC Public Health. 2025 Aug 2;25(1):2637. doi: 10.1186/s12889-025-23847-1.
4
Breast, cervical, and colorectal cancer screening prevalence in the US-Affiliated Pacific Islands.美国附属太平洋岛屿地区乳腺癌、宫颈癌和结直肠癌筛查普及率
Cancer Epidemiol. 2025 Aug;97:102851. doi: 10.1016/j.canep.2025.102851. Epub 2025 Jun 6.
5
The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis.教育水平对乳腺癌和宫颈癌筛查依从性的影响:来自系统评价和荟萃分析的证据。
Prev Med. 2015 Dec;81:281-9. doi: 10.1016/j.ypmed.2015.09.011. Epub 2015 Sep 25.
6
Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.无症状个体中,柔性乙状结肠镜检查与粪便潜血检测用于结直肠癌筛查的比较。
Cochrane Database Syst Rev. 2013 Oct 1;2013(9):CD009259. doi: 10.1002/14651858.CD009259.pub2.
7
Primary care physician involvement increases likelihood of cancer screening in people with cystic fibrosis: A population-based study from Ontario, Canada.初级保健医生的参与增加了囊性纤维化患者进行癌症筛查的可能性:一项来自加拿大安大略省的基于人群的研究。
J Cyst Fibros. 2025 Jul;24(4):698-703. doi: 10.1016/j.jcf.2025.04.004. Epub 2025 Apr 26.
8
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion.州级保险扩展后乳腺密度筛查资格的种族差异
JAMA Netw Open. 2025 Aug 1;8(8):e2525216. doi: 10.1001/jamanetworkopen.2025.25216.
9
Inequality in modern contraceptive use and unmet need for contraception among women of reproductive age in Zambia. A trend and decomposition analysis 2007-2018.赞比亚育龄妇女现代避孕方法使用情况及未满足的避孕需求的不平等。2007 - 2018年趋势与分解分析
Reprod Health. 2024 Dec 9;21(1):181. doi: 10.1186/s12978-024-01909-8.
10
Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010-2019.2010-2019 年日本女性宫颈癌、乳腺癌和结直肠癌筛查参与的社会经济不平等趋势。
Cancer Epidemiol. 2023 Jun;84:102353. doi: 10.1016/j.canep.2023.102353. Epub 2023 Mar 28.

本文引用的文献

1
Papanicolaou test in Brazil: analysis of the National Health Survey of 2013 and 2019.巴西巴氏涂片检查:2013 年和 2019 年国家健康调查分析。
Rev Saude Publica. 2023 Oct 20;57:55. doi: 10.11606/s1518-8787.2023057004798. eCollection 2023.
2
Social inequalities in access to cancer screening and early detection: A population-based study in the city of São Paulo, Brazil.社会不平等与癌症筛查和早期检测机会:巴西圣保罗市的一项基于人群的研究。
Clinics (Sao Paulo). 2023 Jan 19;78:100160. doi: 10.1016/j.clinsp.2022.100160. eCollection 2023.
3
Prevalence of colorectal cancer screening test use by test type and age among older adults in the United States.美国老年人中按检测类型和年龄划分的结直肠癌筛查检测使用率
J Am Geriatr Soc. 2022 Sep;70(9):2722-2725. doi: 10.1111/jgs.17890. Epub 2022 Jun 2.
4
Cancer Screening Prevalence and Associated Factors Among US Adults.美国成年人癌症筛查普及率及相关因素
Prev Chronic Dis. 2022 Apr 21;19:E22. doi: 10.5888/pcd19.220063.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Inequalities in participation in colorectal cancer screening programmes: a systematic review.参与结直肠癌筛查计划的不平等现象:系统评价。
Eur J Public Health. 2020 Jun 1;30(3):416-425. doi: 10.1093/eurpub/ckz236.
7
Factors associated with lack of mammography: National Health Survey, 2013.与未进行乳房X光检查相关的因素:2013年国家健康调查
Rev Bras Epidemiol. 2019 Dec 5;22:e190069. doi: 10.1590/1980-549720190069. eCollection 2019.
8
Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.葡萄牙的前列腺癌筛查:潜在益处和不良反应的流行情况和认知。
Eur J Cancer Prev. 2020 May;29(3):248-251. doi: 10.1097/CEJ.0000000000000539.
9
Health inequalities by region and social group based on data from household surveys (Brazil, 1998-2013).基于家庭调查数据(巴西,1998 - 2013年)的地区和社会群体健康不平等情况
Cien Saude Colet. 2019 Jul 22;24(7):2745-2760. doi: 10.1590/1413-81232018247.15812017.
10
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.前列腺癌筛查中前列腺特异性抗原(PSA)检测的系统评价和荟萃分析。
BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519.